Your Article Summary
Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review
Current Medical Research and Opinion, 06/26/09
Balu S - Despite the lack of uniformity in the cut-off points used in the trials, the follow-up time after administration of therapy, and the amount of time within which treatment is initiated after onset of stroke symptoms, the MRS seems to be more sensitive and responsive as compared to the BI in measuring stroke disability. However, more studies are required to differentiate the BI and the MRS that would help in selecting a scale that would appropriately capture outcomes among stroke patients.
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Modafinil for multiple sclerosis fatigue: Does it work?
Clinical Neurology and Neurosurgery, 12/17/09
Valproate-Induced Hyperammonemic Encephalopathy and Normal Liver Functions: Possible Synergism With Topiramate
Clinical Neuropharmacology, 12/17/09
Neuroleptic Malignant Syndrome or a Statin Drug Reaction? A Case Report
Clinical Neuropharmacology, 12/17/09
Today in Stroke/Vascular...keeping you current
Receive free subspecialty "5-minute updates" via email
A score to predict early risk of recurrence after ischemic stroke
Neurology, 12/17/09
Observation of the embolus protection filter for carotid artery stenting
Surgical Neurology, 12/17/09
Microvascular repair of an injured cortical draining vein
Surgical Neurology, 12/17/09

See Latest Articles